Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
Condition(s):GlioblastomaLast Updated:January 14, 2014Withdrawn
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:January 14, 2014Withdrawn
Condition(s):Esophageal CancerLast Updated:May 22, 2020Completed
Condition(s):GlioblastomaLast Updated:January 17, 2024Recruiting
Condition(s):Head and Neck CancerLast Updated:March 6, 2024Recruiting
Condition(s):Stage III Non-small-cell Lung Cancer; Stage IV Non-small Cell Lung Cancer; Radiotherapy Side EffectLast Updated:September 11, 2023Recruiting
Condition(s):Neoplasm of Rectum; Surgery–Complications; SurgeryLast Updated:July 7, 2017Unknown status
Condition(s):Non-Small Cell Lung Cancer (NSCLC)Last Updated:July 5, 2023Recruiting
Condition(s):Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous CellLast Updated:December 15, 2015Unknown status
Condition(s):Neoplasms; Colorectal Neoplasms; Rectal Diseases; Gastrointestinal NeoplasmsLast Updated:June 12, 2017Completed
Condition(s):Head and Neck Neoplasm; Squamous Cell Carcinoma of Head and NeckLast Updated:April 11, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.